The bill establishes an emergency insulin program in Washington state, allowing eligible individuals to access a 30-day supply of insulin for a maximum out-of-pocket cost of $10, starting January 1, 2026. To qualify, individuals must be Washington residents, not enrolled in medical assistance or prescription drug coverage that limits their cost-sharing for insulin to $35 or less, possess a valid prescription, and have less than a seven-day supply of insulin available. The program will be administered by the health care authority, which will provide a process for individuals to attest to their eligibility and receive an electronic voucher for insulin at a network pharmacy.

Additionally, the bill outlines the responsibilities of network pharmacies and the reimbursement process from the prescription drug purchasing consortium. Pharmacies may collect a dispensing fee of up to $10 and must submit claims for reimbursement within 30 days. The consortium will invoice insulin manufacturers for the costs incurred and requires payment within 30 days of receiving an invoice. The authority is also empowered to impose fines on manufacturers for non-compliance, with collected fines directed to the state health care affordability account. The bill includes provisions for the authority to adopt necessary rules for implementation and mandates the availability of information on manufacturer patient assistance programs on its website.